Lung-Focused Celea Secures $180M for Pivotal Test of Pulmonary Fibrosis Drug
PureTech Well being spinout Celea Therapeutics will apply the financing towards a Section 3 check of its idiopathic pulmonary (IPF) ...
Tag: 180M
Rocket Pharma Reaps $180M From Sale of FDA Drug Review Fast Pass
Rocket Prescription drugs bought its uncommon illness pediatric precedence evaluate voucher for $180 million, money that the corporate will use ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!